Lupin’s arm recalls Morphine Sulfate extended-release tablets in US

06 May 2019 Evaluate

Lupin’s subsidiary -- Novel Laboratories’ Somerset facility is recalling 46,700 bottles of Morphine Sulfate extended-release tablets, used to treat severe pain, in the US market. The recalling is in various strengths due to failed impurities/degradation specifications.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2176.25 -18.75 (-0.85%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×